Tango Therapeutics, Inc. revenue breakdown overview

Tango Therapeutics, Inc. revenue for the last year amounted to 42.07 M USD, the most of which — 42.07 M USD — came from its highest performing source at the moment, Oncology Therapies, the year earlier bringing 36.53 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Tango Therapeutics, Inc. 42.07 M USD, and the year before that — 36.53 M USD.